NCT02206425 2023-10-31Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma PatientsOncotherapeuticsPhase 1/2 Completed45 enrolled
NCT02186834 2023-01-04Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple MyelomaH. Lee Moffitt Cancer Center and Research InstitutePhase 1/2 Completed28 enrolled 10 charts
NCT00846612 2019-09-30Pharmacokinetic Study of Avastin and Doxil in Ovarian CancerNYU Langone HealthPhase 1 Completed15 enrolled